Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA
Clinical trial NCT04156620 · COMPLETED
Trial details
- NCT number
- NCT04156620
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-11
- Primary completion
- 2022-02-17
- Enrollment
- 527
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.